Danish Randomized Trial on Leadless vs Transvenous Pacing
NCT: NCT05856799 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to evaluate the quality of life, patient acceptance and exercise capacity with leadless compared to transvenous pacing in elderly patients with new-onset high-grade atrioventricular block. Consecutive patients with high-grade atrioventricular black and preserved sinus node function with indication for permanent pacemaker implantation according to the latest european guidelines, are included in a prospective, partly patient and accessor blinded and partly open label, 1:1 randomized combined parallel and cross-over trial to implantation with 1) a Micra AV Transcathter Pacing System or 2) an Azure XT DR dual chamber pacemaker.
Frequently Asked Questions
What is Danish Randomized Trial on Leadless vs Transvenous Pacing?
Danish Randomized Trial on Leadless vs Transvenous Pacing is a clinical trial registered under NCT05856799. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05856799?
The current status of NCT05856799 (Danish Randomized Trial on Leadless vs Transvenous Pacing) is: ACTIVE_NOT_RECRUITING.
When did Danish Randomized Trial on Leadless vs Transvenous Pacing start?
Danish Randomized Trial on Leadless vs Transvenous Pacing started on 2023-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.